INTRODUCTION {#sec1}
============

Staphylococcus epidermidis is a common opportunistic pathogen that is present on human skin and mucosal surfaces. The pathogenicity of S. epidermidis is mainly due to biofilm formation on foreign devices, such as catheters, heart valves, and prostheses ([@B1], [@B2]). The bacteria within the biofilm are protected against killing by antibiotics and the host immune system, contributing to the increasing emergence of resistance to antimicrobial drugs and to the establishment of persistent infections ([@B3], [@B4]). PhoU, the phosphate transport system regulatory protein, is now known to be a negative regulator of drug tolerance in Escherichia coli, Mycobacterium tuberculosis, and Pseudomonas aeruginosa ([@B5][@B6][@B8]), whereas the possible role of PhoU in biofilm formation and drug tolerance in S. epidermidis has not been investigated.

On the basis of a crystal structure analysis of PhoU in Thermotoga maritima ([@B9]), multinuclear iron clusters \[E(D)XXXD\] have been identified to be the conserved motif of the protein. According to the conserved motif, one homolog of *phoU* is found in E. coli, P. aeruginosa, and Streptococcus, while two *phoU* homologs are found in T. maritima, M. tuberculosis, Mycobacterium marinum, and Staphylococcus aureus. In E. coli and P. aeruginosa, *phoU* is located in the *pst* operon, which contains four other genes: *pstS*, *pstA*, *pstC*, and *pstB*. PstS is a periplasmic inorganic phosphate (P~i~)-binding protein that captures and transfers P~i~ to the channel formed by the integral proteins PstC and PstA in the cytoplasmic membrane. PstB is an ATPase that provides the energy for transport ([@B10]). The last gene in the operon, *phoU*, encodes a protein that does not have a defined function. In 2007, it was reported that *phoU* in E. coli plays an important role in the development of multidrug-tolerant bacteria ([@B5]). In P. aeruginosa, *phoU* is a negative regulator of intracellular ppGpp and polyphosphate (polyP), but it does not regulate biofilm formation ([@B8]). In M. tuberculosis and M. marinum, there are two *phoU* homologs in the genome, *phoY1* and *phoY2*. However, neither *phoY1* nor *phoY2* is located in the *pst* operon. In the two mycobacterial species, *phoY2* was shown to be a functional homolog of *phoU*, regulating the generation of multidrug-tolerant bacteria and maintaining metabolic homeostasis and adaptation to stress conditions ([@B6], [@B7]). In the S. aureus (NCTC8325) genome, there are two *phoU* homologs (*SAOUHSC_01384* and *SAOUHSC_00669*). In S. aureus, *SAOUHSC_01384* resides in the *pst* operon as *phoU*, while *SAOUHSC_00669* (*pitR*) also contains the conserved motif of *phoU* and is located upstream of *pitA* (a phosphate uptake gene). A point mutation in *pitA* in S. aureus resulted in bacteria that were sensitized to daptomycin, and SAOUHSC_00669 was found to be required for daptomycin sensitivity ([@B11], [@B12]). In the present study, protein motif analysis of S. epidermidis ATCC 35984 revealed two genes that were homologous to *phoU* (*serp0956* and *serp0316*). *serp0956*, found in the *pst* operon, was named *phoU1*, while *serp0316*, located upstream of a hypothetical protein with a high degree of homology to *pitR* of S. aureus, was named *phoU2*.

In staphylococci, biofilm formation and drug tolerance are regulated by multiple regulatory factors ([@B13], [@B14]). In this study, we focused on investigating the roles of PhoU homologs in the biofilm formation and drug tolerance of S. epidermidis. In S. epidermidis strain 1457 (SE1457), either *phoU1* or *phoU2* was deleted by allelic replacement to create the Δ*phoU1* and Δ*phoU2* mutants, respectively. The effects of these deletions on bacterial growth, biofilm formation, drug tolerance, and oxidative stress were investigated. Comparison of the transcriptomes of the Δ*phoU2* mutant and the parent strain revealed the differentially expressed genes (DEGs) involved in the pentose phosphate (PPP) pathway, galactose metabolism, the trichloroacetic acid (TCA) cycle, glycolysis and gluconeogenesis, and respiratory chain reactions. The involvement of some of the DEGs in metabolic processes, such as polyP accumulation, ATP accumulation, and the pentose phosphate pathway, was validated. We conclude that *phoU2* probably regulates bacterial growth, biofilm formation, oxidative stress responses, and drug tolerance in S. epidermidis. In contrast, *phoU1* has no obvious effect on biological activity in S. epidermidis.

RESULTS {#sec2}
=======

The two *phoU* loci identified in the genome of S. epidermidis. {#sec2-1}
---------------------------------------------------------------

In the genome of the S. epidermidis ATCC 35984 strain (GenBank accession number [CP000029](https://www.ncbi.nlm.nih.gov/nucleotide/CP000029)), two PhoU gene homologs, *serp0956* and *serp0316*, were identified by bioinformatics analysis (<https://www.ncbi.nlm.nih.gov/genome/?term=RP62a>) on the basis of the conserved motif E(D)XXXD of Thermotoga maritima. *serp0956* is located in the *pst* operon, similarly to the *phoU* gene in E. coli, which is denoted as encoding a phosphate transport system regulatory protein and designated *phoU1* in this study. *serp0316*, denoted *phoU2*, encodes a hypothetical protein, is located far from the *pst* operon, and was cotranscribed with the adjacent gene, *serp0317* ([Fig. 1](#F1){ref-type="fig"}). The two PhoU homologs in S. epidermidis shared 12.5% identity and 30.1% consensus sequences.

![Two genes homologous to *phoU*, *phoU1* and *phoU2*, were found in S. epidermidis RP62A by motif analysis according to the PhoU conserved motifs \[E(D)XXXD\] of Thermotoga maritima. (A) Genetic locations of *phoU1* and *phoU2* in S. epidermidis RP62A. (B) Genetic organization of the *pst* operon and *phoU* in E. coli.](zjb9990945940001){#F1}

Construction of *phoU1* and *phoU2* deletion strains. {#sec2-2}
-----------------------------------------------------

To identify the function of *phoU1* or *phoU2* in S. epidermidis, mutants of the SE1457 strain with a deletion of *phoU1* or *phoU2* were constructed using the temperature-sensitive plasmid pKOR1. The deletion mutants were verified by PCR, reverse transcription (RT)-quantitative PCT (qPCR), and direct sequencing and are referred to as the Δ*phoU1* and Δ*phoU2* mutants, respectively. The complemented Δ*phoU2* strain was constructed using shuttle vector pCN51 and named SE1457 Δ*phoU2*/pCN51::*phoU2*. The Δ*phoU*2 strain containing the empty vector pCN51 was designated SE1457 Δ*phoU2*/pCN51.

Growth curves of the Δ*phoU1* and Δ*phoU2* mutants. {#sec2-3}
---------------------------------------------------

To evaluate the effect of *phoU1* or *phoU2* knockout on the growth of S. epidermidis, growth curves of the Δ*phoU1* and Δ*phoU2* mutants and the parent strain (SE1457) were generated under oxic and microaerobic conditions.

Under oxic conditions, in comparison to the parent strain, the Δ*phoU2* mutant displayed a marked reduction in growth ([Fig. 2A](#F2){ref-type="fig"}). However, the Δ*phoU1* mutant displayed growth curves and colony sizes similar to those of the parent strain when the strains were incubated under the same conditions. By culture in liquid tryptic soya broth (TSB) medium at 37°C for 6 h, the optical density at 600 nm (OD~600~) of the Δ*phoU2* mutant reached 1.26 ± 0.343, and that of the parent strain was 2.41 ± 0.078. On solid culture medium (TSB agar), the colony size of the Δ*phoU2* mutant was much smaller than that of the parent strain ([Fig. 2C](#F2){ref-type="fig"}). The expression of *phoU2* by the pCN51 vector restored the growth of the Δ*phoU2* mutant to the level of the parent strain.

![Effect of *phoU2* deletion on the growth of S. epidermidis. Overnight cultures of the Δ*phoU1*, Δ*phoU2*, and SE1457 strains were diluted 1:200 into 10 ml TSB in a conical flask in a volume of 100 ml and incubated with shaking at 220 rpm. Bacterial growth was monitored by measuring the OD~600~ for 12 h. Data (means ± SDs) are from three independent experiments. (A) Growth curves of the Δ*phoU1* and Δ*phoU2* mutants under oxic conditions. (B) Growth curves of Δ*phoU1* and Δ*phoU2* mutants under microaerobic conditions. (C) Representative images showing the colony morphology of the Δ*phoU1* and Δ*phoU2* mutants and the SE1457 parent strain grown on TSB agar plates at 37°C for 24 h under oxic conditions. The results represent those from one of three independent experiments.](zjb9990945940002){#F2}

Under microaerobic conditions, the growth rates of the Δ*phoU1* and Δ*phoU2* mutants and SE1457 in liquid medium were measured by recording the OD~600~ of the cultures. After 6 h of incubation, the OD~600~ of the Δ*phoU2* mutant was 0.265 ± 0.04, which was much less that than that of SE1457 (0.418 ± 0.03) ([Fig. 2B](#F2){ref-type="fig"}). However, no differences in the growth curve could be detected in the Δ*phoU1* mutant when the strains were incubated under the same conditions.

Morphology and autolysis of the Δ*phoU1* and Δ*phoU2* mutants. {#sec2-4}
--------------------------------------------------------------

The morphologies of the Δ*phoU1* and Δ*phoU2* mutants and the parent strain were observed using transmission electron microscopy (TEM). A rough cell wall and thin cytoplasm were observed in the Δ*phoU2* mutant (magnification, ×26,500), while the morphology of the Δ*phoU1* mutant was similar to that of the parent strain ([Fig. 3A](#F3){ref-type="fig"}).

![(A) Bacterial morphology of the Δ*phoU1* and Δ*phoU2* mutants observed by TEM. The ultrastructure of the log-phase bacteria was observed by transmission electron microscopy (Philips Tecnai-12 Biotwin). Arrow, disruption of the cell wall in the Δ*phoU2* mutant. (B) Autolysis of the Δ*phoU1* and Δ*phoU2* mutants induced by Triton X-100. Overnight cultures were suspended in Triton X-100 autolysis buffer (50 mM glycine, pH 8.0, containing 0.01% Triton X-100) to an initial OD~600~ of approximately 1.0, and the rates of autolysis were monitored on the basis of the decrease in the OD~600~ value over time.](zjb9990945940003){#F3}

The autolysis capacity of the Δ*phoU1* and Δ*phoU2* mutants and the parent strain was then assessed by Triton X-100 induction. Mid-exponential-phase cultures (6 h) of the Δ*phoU1* and Δ*phoU2* mutants and SE1457 were adjusted to an OD~600~ of 1.0 and incubated with 0.05% Triton X-100 for 5 h, and the autolysis rate was measured by determination of the OD~600~ using a spectrophotometer. After Triton X-100 induction, the autolysis rate of the Δ*phoU2* mutant reached 88% after treatment for 3 h, which was significantly higher than that of SE1457 (46%). The autolysis rate of Δ*phoU1* (43%) was similar to that of the parent strain ([Fig. 3B](#F3){ref-type="fig"}).

Biofilm formation of the Δ*phoU1* and Δ*phoU2* mutants under static or hydrodynamic conditions. {#sec2-5}
-----------------------------------------------------------------------------------------------

Under static conditions, the polystyrene microtiter plate assay and the confocal laser scanning microscopy (CLSM) observation assay were performed to evaluate the role of *phoU1* or *phoU2* in biofilm formation. Bacterial biofilm formation was monitored at 6, 12, 24, and 48 h on microtiter plates stained with crystal violet, and the OD~570~ was read. The mature biofilm of the Δ*phoU2* mutant (OD~570~, 1.56 ± 0.10) was significantly decreased compared with that of the parent strain (OD~570~, 3.04 ± 0.08) after incubation for 24 h, and the Δ*phoU1* deletion (OD~570~, 2.58 ± 0.02) had little effect on biofilm formation ([Fig. 4](#F4){ref-type="fig"}). The complemented Δ*phoU2/*pCN51::*phoU2* strain (OD~570~, 2.77 ± 0.12) showed a restored biofilm formation ability.

![Biofilm (BF) formation by the Δ*phoU1* and Δ*phoU2* mutants on microtiter plates. Overnight cultures of the S. epidermidis strains were diluted 1:200 with fresh TSB, added to 96-well polystyrene plates in triplicate, and cultured under static conditions for 6 h, 12 h, 24 h, and 48 h. After the biofilms were washed, they were stained with crystal violet. The OD~570~s of the plates were analyzed. The experiments were repeated three times, and the data represent means ± SDs. \*\*, *P* \< 0.01.](zjb9990945940004){#F4}

Furthermore, the biofilm formation ability of the Δ*phoU2* mutant *in vitro* was examined by confocal laser scanning microscopy. After incubation at 37°C for 24 h, SE1457 formed a compact, thick biofilm on a glass coverslip in a cell culture dish. In contrast, the biofilm of the Δ*phoU2* mutant was much thinner than that of the parent strain. Additionally, the dead cell ratio in the biofilm of the Δ*phoU2* mutant (6.7%) was 5-fold higher than that in the biofilm of the parent strain (1.3%) ([Fig. 5](#F5){ref-type="fig"}).

![Biofilms of the Δ*phoU1* and Δ*phoU2* mutants observed by CLSM. Twenty-four-hour-old biofilms of SE1457 and the Δ*phoU1* and Δ*phoU2* mutants were grown on a cover glass in a cell culture dish and observed by CLSM. Three-dimensional (3-D) structural images (zoom 1, ×63 magnification) were reconstructed, and the thickness of the biofilms was measured using Imaris software. Viable and dead cells were stained green (SYTO9) and red (PI), respectively. The amount of fluorescence in the middle layer of the biofilm was determined using ImageJ software (zoom 3, ×63 magnification). The PI/total florescence value indicates the proportion of dead cells within the biofilm. The images and values are representative of those from one of three independent experiments.](zjb9990945940005){#F5}

Under hydrodynamic conditions, the biofilm formation of the Δ*phoU2* mutant strain was analyzed using a BioFlux 1000 device with a flow speed of 0.15 dyne/cm^2^. The maximum size of the biofilm of the Δ*phoU2* mutant observed in the channel was 2-fold smaller than that of the biofilm of the parent strain and the complemented strain, and the time required to form the maximum biofilm was 5.4 h longer for the Δ*phoU2* mutant strain than for the parent strain ([Fig. 6](#F6){ref-type="fig"}). The biofilm formation of the Δ*phoU1* mutant in the hydrodynamic state appeared to be similar to that of the parent strain. The complemented Δ*phoU2/*pCN51::*phoU2* strain could partially restore the biofilm formation capacity under hydrodynamic conditions.

![Biofilm formation by the Δ*phoU1* and Δ*phoU2* mutants under hydrodynamic conditions. Overnight cultures of the S. epidermidis strains were diluted 1:200 with fresh TSB and added to BioFlux 48-well plates. The bacteria were then cultured under hydrodynamic conditions with a shear setting of 0.15 dyne/cm^2^. A BioFlux 1000 system (Fluxion Biosciences) with a Leica microscope and temperature-controlled housing was used for all imaging experiments. Automated microscopy and image processing were performed with BioFlux Montage software. Images were automatically acquired every 10 min at multiple stage positions with bright-field illumination; images were also acquired in the red channel using a 200-ms exposure time. The background-corrected average pixel intensity per image was used to quantify the biofilm formation by the different strains. The curve was generated on the basis of the images. A synthesis of the images is shown in Movies S1 to S5 in the supplemental material. Each figure represents the results of one of three independent experiments.](zjb9990945940006){#F6}

The initial attachment phase is characterized as the first phase of the process of Staphylococcus epidermidis biofilm formation. The initial attachment capacity of the Δ*phoU2* mutant was determined, and the attached cells were counted using ImageJ software. There were fewer attached cells for the Δ*phoU2* mutant (3.32 × 10^6^) than for the parent strain (2.70 × 10^7^) and the complemented strain Δ*phoU2/*pCN51::*phoU2* (2.33 × 10^7^). The number of attached cells of the Δ*phoU1* mutant (2.47 × 10^7^) was similar to the number of attached cells of the parent strain ([Fig. 7](#F7){ref-type="fig"}).

![Initial attachment of the Δ*phoU1* and Δ*phoU2* mutants on polystyrene plates. Log-phase bacterial cultures in TSB were adjusted to an OD~600~ of 0.1 with PBS, and 5-ml aliquots were added to a 6-well polystyrene plate. After incubation at 37°C for 30 min, each well was washed three times with PBS, and the adhered cells were observed and photographed. The amounts of attached bacterial cells of the Δ*phoU1* and Δ*phoU2* mutants and SE1457 are indicated. The results (means ± SDs) are from three independent experiments. \*\*\*, *P* \< 0.001.](zjb9990945940007){#F7}

To investigate the effect of the *phoU2* deletion on biofilm matrix production, the release of accumulation-associated protein (Aap), polysaccharide intercellular adhesion (PIA), and extracellular DNA (eDNA) was determined for SE1457 and the Δ*phoU1* and Δ*phoU2* mutants. The production of Aap was reduced in the biofilm of the Δ*phoU2* mutant compared with that in the biofilm of the parent strain ([Fig. 8A](#F8){ref-type="fig"}), as determined by Western blotting with monoclonal antibody 18B6 (MAb~18B6~) against the Aap protein B repeat region. PIA production was similar in the Δ*phoU2* mutant biofilm and the parent strain, as determined semiquantitatively with a wheat germ agglutinin (WGA)-horseradish peroxidase (HRP) conjugate using a dot blot 96 system ([Fig. 8B](#F8){ref-type="fig"}). The relative concentration of eDNA in the 24-h-old biofilm of the Δ*phoU2* mutant was similar to that in the parent strain ([Fig. 8C](#F8){ref-type="fig"}). All *P* values were \>0.05, so there were no differences in the levels of transcription of *serp0306*, *leuA*, or *lysA* between biofilm bacteria of the PhoU mutants and the parent strain. The levels of PIA, Aap, and eDNA production were similar in the Δ*phoU1* mutant and the parent strain.

![Effects of the Δ*phoU1* and Δ*phoU2* mutants on extracellular matrix biosynthesis by S. epidermidis. (A) Aap expression in the Δ*phoU1* and Δ*phoU2* mutants. Twenty-four-hour-old biofilms and 12-h-old planktonic bacteria were collected after they were washed with PBS. Lysostaphin-treated samples with identical OD~600~s were centrifuged at 20,000 × *g* for 30 min at 4°C. The supernatant was separated by 7% SDS-PAGE, and the gel pieces containing Aaps were used for Western blotting (top).The remaining gel pieces were stained with Coomassie blue as an endogenous reference (bottom). MAb~18B6~ (10 ng/ml) was used as the primary antibody. Immunoreactivity was detected using an ECL Western blotting system after incubation with HRP-conjugated secondary antibody. (B) PIA biosynthesis was semiquantified using a dot blot assay with WGA. Twenty-four-hour-old biofilms were scraped off and suspended in EDTA. Serial dilutions of the PIA assay extracts were spotted onto nitrocellulose membranes, subsequently incubated with WGA conjugated to HRP, and visualized by chromogenic detection. (C) eDNA quantified by qPCR of four chromosomal loci (*gyrB*, *serp0306*, *leuA*, and *lysA*). The OD~600~s of unwashed 24-h-old biofilms were measured for normalization to the biofilm biomass, and then the biofilms were used for eDNA isolation by phenol-chloroform-isoamyl alcohol extraction and ethanol precipitation. The results are presented as the amount of eDNA per biofilm biomass (means ± SDs) from three independent experiments.](zjb9990945940008){#F8}

Antibiotic tolerance of the Δ*phoU1* and Δ*phoU2* mutants. {#sec2-6}
----------------------------------------------------------

Antibiotic-tolerant bacteria were identified using a modification of a procedure described by Li and Zhang ([@B5]). Both the MIC and the minimal bactericidal concentration (MBC) for the Δ*phoU1* and Δ*phoU2* mutants were similar to those for the parent strain. To determine the antibiotic concentrations that ensured that only drug-tolerant bacterial cells survived, killing curves were determined for each antibiotic used in the present study. To detect the drug tolerance of the bacterial mutants, in which the size of the population of bacteria was not decreased with an increase in the antibiotic concentration, the concentrations of antibiotics were as follows: vancomycin, 75 μg/ml (96× MIC); levofloxacin, 75 μg/ml (128× MIC); amikacin, 50 μg/ml (128× MIC).

An overnight culture (16 h) of S. epidermidis was inoculated into fresh TSB (at 1:100) containing the antibiotics at the specific concentrations, and the culture was incubated at 37°C for 5 days. At different time points, the surviving bacteria were counted. After exposure to the three antibiotics for 72 h, the antibiotic tolerance of the Δ*phoU2* mutant was dramatically reduced, and no viable bacteria were detected. In contrast, the Δ*phoU1* mutant displayed an antibiotic tolerance similar to that of the parent strain (greater than 10^4^ CFU) ([Table 1](#T1){ref-type="table"}). The complementation of the Δ*phoU2* mutant strain restored the antibiotic tolerance.

###### 

Survival of the Δ*phoU1* and Δ*phoU2* mutants and the parent strain with antibiotic exposure over time[^*a*^](#T1F1){ref-type="table-fn"}

  Time point   No. of CFU/ml                                                                                                                                                                                        
  ------------ --------------- ------------- ------------- -------------- ------------- ------------- ------------- ----------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  Start        8 × 10^9^       8 × 10^9^     8 × 10^9^     8.7 × 10^9^    8.7 × 10^9^   8.7 × 10^9^   9 × 10^9^     9 × 10^9^   9 × 10^9^     8.5 × 10^9^   8.5 × 10^9^   8.5 × 10^9^   8.7 × 10^9^   8.7 × 10^9^   8.7 × 10^9^
  12 h         6 × 10^6^       4 × 10^6^     7.2 × 10^6^   8 × 10^6^      7.8 × 10^6^   4.4 × 10^6^   8 × 10^5^     5 × 10^4^   6 × 10^5^     6.8 × 10^6^   5 × 10^6^     7.8 × 10^6^   7.6 × 10^6^   5.7 × 10^4^   4 × 10^5^
  24 h         3.2 × 10^6^     3.6 × 10^6^   5 × 10^5^     6 × 10^6^      5 × 10^6^     4 × 10^6^     5 × 10^5^     2 × 10^3^   1 × 10^5^     4 × 10^6^     3.5 × 10^6^   2 × 10^6^     3.5 × 10^5^   5 × 10^3^     2.4 × 10^4^
  36 h         9.2 × 10^5^     7 × 10^5^     4 × 10^5^     1.2 × 10^6^    2.4 × 10^6^   2 × 10^6^     5.4 × 10^5^   0           6 × 10^4^     2.2 × 10^6^   8 × 10^5^     7 × 10^5^     4 × 10^4^     0             2 × 10^3^
  48 h         1.3 × 10^6^     5 × 10^5^     8.8 × 10^4^   1.28 × 10^6^   3 × 10^6^     5 × 10^5^     4 × 10^4^     0           1.2 × 10^4^   7 × 10^5^     8 × 10^5^     4.5 × 10^5^   2.4 × 10^3^   0             0
  72 h         4.4 × 10^6^     2 × 10^5^     6 × 10^4^     2.57 × 10^6^   5 × 10^5^     4 × 10^5^     0             0           0             5 × 10^5^     4.6 × 10^5^   9 × 10^4^     0             0             0
  96 h         6 × 10^6^       7 × 10^5^     4 × 10^4^     9 × 10^6^      6.6 × 10^5^   1 × 10^5^     0             0           0             7.2 × 10^5^   5 × 10^5^     7.5 × 10^4^   0             0             0
  120 h        1.9 × 10^5^     6 × 10^5^     1.9 × 10^4^   6 × 10^6^      4 × 10^5^     8 × 10^4^     0             0           0             2.4 × 10^5^   4.5 × 10^5^   5 × 10^4^     0             0             0

The susceptibilities of stationary-phase cultures of the Δ*phoU1* and Δ*phoU2* mutants and the SE1457 parent strain to vancomycin (Van; 75 μg/ml), levofloxacin (Lev; 75 μg/ml), and amikacin (Ami; 50 μg/ml) were determined. The numbers of CFU were determined at different times of exposure of stationary-phase cultures of these strains to the indicated antibiotics.

Comparison of the transcriptomes of the Δ*phoU2* mutant and the parent strain. {#sec2-7}
------------------------------------------------------------------------------

To compare the transcriptional profile of the Δ*phoU1* or Δ*phoU2* mutant with that of SE1457, RNA was extracted from logarithmic-phase (6 h) and stationary-phase (10 h) bacteria and detected by transcriptome sequencing (RNA-Seq). The sequencing libraries were prepared in triplicate for the Δ*phoU1* and Δ*phoU2* mutants and the parent strain. For each biological replicate, 10 million raw reads were generated. After the removal of ambiguous and low-quality reads, more than 90% of the reads mapped to strain ATCC 35984.

A gene with a false discovery rate (FDR)-adjusted *P* value of less than 0.05 (*t* test), a *q* value of less than 0.05, and at least a 1.5-fold change in the transcript level between the mutant and the parent strain was considered to be differentially expressed. In logarithmic phase (6 h), 945 genes were identified to be differentially expressed between the Δ*phoU2* mutant and the parent strain; among these, 474 genes were upregulated and 471 were downregulated. In the stationary phase (10 h), 995 DEGs were identified; among these, 716 genes were upregulated and 279 were downregulated. By comparison and analysis, 439 DEGs were identified in the different phases of both the Δ*phoU2* mutant and the parent strain. Among these genes, 256 showed the same expression tendency. However, there were only 92 genes differentially expressed between the Δ*phoU1* mutant and the parent strain during logarithmic phase and 2 DEGs during the stationary phase. Therefore, we focused on analyzing the genes differentially expressed between the Δ*phoU2* mutant and the parent strain. We selected 70 of the DEGs for validation by RT-qPCR. Among them, the transcription of 62 genes in the Δ*phoU2* mutant was consistent with the tendency observed by RNA-Seq. The other 8 genes determined by RT-qPCR displayed a fold change in expression below the cutoff value of 2.

Among the DEGs, the transcription of *yycFG*, an essential two-component system for regulating bacterial growth, in the Δ*phoU2* mutant was downregulated 3-fold compared with its expression in the parent strain ([@B15]). Transcription of the anaerobic growth-regulated genes *pflA*, *nrdD*, and *nrdG* was downregulated in the Δ*phoU2* mutant ([@B16][@B17][@B19]). The expression of *rsbU* (a sigma factor B regulatory protein), which is involved in biofilm formation, was also downregulated ([@B20]). Transcription of the autolysis genes *ssaA* (*serp2136*, *serp1880*, *serp1884*, *serp2120*) and *serp0318* was upregulated in the Δ*phoU2* mutant, while the gene for autolysin E (*atlE*) was not found among the DEGs ([@B21][@B22][@B23]). Expression of the *pst* operon and *phoR*, involved in inorganic phosphate metabolism, was upregulated in the Δ*phoU2* mutant, while that of the *phn* ABC transporter, which participates in phosphonate metabolism, was downregulated. The expression of ATP synthase was upregulated ([Table 2](#T2){ref-type="table"}).

###### 

Genes differentially expressed between the Δ*phoU2* mutant and the parent strain

  Gene function and gene       GenBank accession no. (location)                                                     Description of product                                                Fold change in expression by:   
  ---------------------------- ------------------------------------------------------------------------------------ --------------------------------------------------------------------- ------------------------------- ---------------
  Growth                                                                                                                                                                                                                  
      *yycF*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2591084--2591786)   DNA-binding response regulator YycF                                   0.35                            0.25 ± 0.08
      *yycG*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2587909--2591072)   Sensor                                                                0.33                            0.31 ± 0.14
      *pflA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2411377--2412133)   Pyruvate formate-lyase-activating enzyme                              0.14                            0.12 ± 0.02
      *nrdG*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2215127--2217511)   Anaerobic ribonucleoside triphosphate reductase-activating protein    0.31                            ND
      *nrdD*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2215127--2217511)   Anaerobic ribonucleoside triphosphate reductase                       0.27                            0.30 ± 0.14
  Biofilm formation                                                                                                                                                                                                       
      *icaR*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2333497--2334055)   Intercellular adhesion regulator                                      4.58                            4.20 ± 1.14
      *serp0719*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (713668--716143)     Cell wall surface anchor family protein                               0.18                            0.13 ± 0.04
      *rsbU*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1724456--1725458)   Sigma factor B regulatory protein                                     0.31                            ND
  Autolysis                                                                                                                                                                                                               
      *serp1880*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1904430--1905204)   Secretory antigen precursor SsaA                                      3.56                            ND
      *serp1884*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1909382--1909856)   Secretory antigen precursor SsaA                                      9.47                            ND
      *serp2120*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2144621--2145053)   Secretory antigen precursor SsaA-related protein                      1.92                            ND
      *serp2136*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2161088--2161862)   Secretory antigen precursor SsaA                                      3.03                            ND
      *serp0318*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (322333--323134)     LysM domain-containing protein                                        1.86                            ND
  Phosphate transport system                                                                                                                                                                                              
      *serp0956*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (972985--973633)     Phosphate transport system regulatory protein PhoU                    5.10                            48.95 ± 6.43
      *serp0957*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (973639--974515)     Phosphate transporter ATP-binding protein                             3.75                            67.96 ± 12.14
      *serp0958*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (974602--975508)     Phosphate ABC transporter permease                                    2.29                            ND
      *serp0959*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (975509--976436)     Phosphate ABC transporter permease                                    3.32                            ND
      *serp0960*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (976642--977620)     Phosphate ABC transporter phosphate-binding protein                   16.46                           ND
      *serp2283*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2323913--2325526)   Phosphonate ABC transporter permease                                  0.31                            ND
      *serp2284*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2323913--2325526)   Phosphonate ABC transporter permease                                  0.31                            ND
      *serp2285*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2325527--2326301)   Phosphonate ABC transporter ATP-binding protein                       0.26                            ND
      *serp2286*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2326414--2327371)   Phosphonate ABC transporter substrate-binding protein                 0.27                            ND
      *serp0317*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (321130--322141)     Phosphate transporter family protein                                  0.20                            0.35 ± 0.09
      *malA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1114440--1116096)   Alpha-glucosidase                                                     0.38                            ND
      *lacD*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1838482--1839460)   Tagatose-1,6-diphosphate aldolase                                     0.09                            ND
      *lacA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1840938--1841367)   Galactose-6-phosphate isomerase subunit LacA                          0.06                            0.13 ± 0.03
      *lacG*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1834966--1836379)   6-Phospho-beta-galactosidase                                          0.24                            0.33 ± 0.07
      *galU*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2080817--2081684)   UTP-glucose-1-phosphate uridylyltransferase                           0.47                            ND
      *lacF*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1838148--1838463)   PTS system, lactose-specific IIA component                            0.12                            ND
      *serp2055*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2078963--2080604)   Phosphoglucomutase/phosphomannomutase                                 0.51                            ND
      *lacC*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1839463--1840396)   Tagatose-6-phosphate kinase                                           0.09                            ND
  Glycolysis/gluconeogenesis                                                                                                                                                                                              
      *gntK*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2083340--2084882)   Gluconokinase                                                         0.19                            0.33 ± 0.12
      *pgi*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (535899--537231)     Glucose-6-phosphate isomerase                                         0.51                            ND
      *fruK*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (355255--356931)     1-Phosphofructokinase                                                 21.66                           ND
      *fbaA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1771076--1771937)   Fructose-bisphosphate aldolase                                        1.74                            ND
      *gapA2*                  [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1287162--1288188)   Glyceraldehyde-3-phosphate dehydrogenase                              0.62                            ND
      *pgk*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (447676--448867)     Phosphoglycerate kinase                                               0.35                            ND
      *gpmA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2023859--2024546)   Phosphoglyceromutase                                                  0.23                            ND
      *ppdK*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2199426--2202054)   Pyruvate phosphate dikinase                                           0.10                            0.03 ± 0.01
      *serp2133*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2158590--2159589)   [d]{.smallcaps}-Lactate dehydrogenase                                 1.54                            ND
      *serp2112*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2135451--2136504)   Alcohol dehydrogenase                                                 0.03                            0.38 ± 0.09
      *serp2076*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2100972--2102937)   Fructose-1,6-bisphosphatase                                           0.39                            ND
  Pentose phosphate pathway                                                                                                                                                                                               
      *pgi*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (535899--537231)     Glucose-6-phosphate isomerase                                         0.51                            ND
      *xylB*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2123183--2124674)   [d]{.smallcaps}-Xylulose kinase                                       0.63                            ND
      *gdh*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1867994--1868786)   Glucose-1-dehydrogenase                                               3.52                            ND
      *deoC*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1784622--1785397)   Deoxyribose-phosphate aldolase                                        0.62                            ND
      *prsA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (128258--129224)     Ribose-phosphate pyrophosphokinase                                    0.62                            ND
      *tkt*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (920891--922880)     Transketolase                                                         0.59                            ND
      *serp2076*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2100972--2102937)   Fructose-1,6-bisphosphatase                                           0.39                            ND
      *gntK*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2083340--2084882)   Gluconokinase                                                         0.19                            ND
      *deoB*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1781738--1783276)   Phosphopentomutase                                                    0.62                            ND
      *zwf-2*                  [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1111611--1113096)   Glucose-6-phosphate 1-dehydrogenase                                   0.56                            ND
      *serp2055*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2078963--2080604)   Phosphoglucomutase/phosphomannomutase                                 0.51                            ND
      *rpe*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (788507--789152)     Ribulose-phosphate 3-epimerase                                        0.65                            ND
      *acnA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (932350--935056)     Aconitate hydratase                                                   0.64                            ND
      *icd*                    [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1296194--1297463)   Isocitrate dehydrogenase                                              0.46                            ND
      *serp2324*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2360268--2361546)   Branched-chain alpha-keto acid dehydrogenase subunit E2               0.24                            ND
      *sucC*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (815833--817000)     Succinyl coenzyme A synthetase subunit beta                           1.78                            ND
      *sdhB*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (730805--733414)     Succinate dehydrogenase iron-sulfur subunit                           0.20                            ND
      *sdhA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2118832--2119732)   Succinate dehydrogenase flavoprotein subunit                          0.17                            ND
      *fumC*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1444325--1445711)   Fumarate hydratase                                                    0.51                            ND
      *sucA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1002484--1005289)   2-Oxoglutarate dehydrogenase E1                                       0.44                            ND
      *sucB*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1001203--1002466)   Dihydrolipoamide succinyltransferase                                  0.25                            ND
      *mqo-3*                  [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2350000--2351497)   Malate:quinone oxidoreductase                                         0.43                            ND
      *mqo-1*                  [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1970555--1972034)   Malate:quinone oxidoreductase                                         0.48                            ND
      *pckA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1409888--1411481)   Phosphoenolpyruvate carboxykinase                                     0.53                            ND
      *serp0857*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (868756--869623)     2-Oxoglutarate ferredoxin oxidoreductase subunit beta                 0.56                            ND
      *serp0856*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (866995--868756)     Pyruvate ferredoxin oxidoreductase, alpha subunit                     0.44                            ND
      *serp2325*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2361559--2362600)   Acetoin dehydrogenase, E1 component, beta subunit                     0.33                            ND
      *serp2327*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2363665--2365018)   Acetoin dehydrogenase, E3 component, dihydrolipoamide dehydrogenase   1.55                            ND
      *serp1076*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1120885--1122205)   2-Oxoisovalerate dehydrogenase E2                                     0.51                            ND
      *serp1077*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1122217--1124192)   2-Oxoisovalerate dehydrogenase E1                                     0.40                            ND
      *serp1078*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1122217--1124192)   2-Oxoisovalerate dehydrogenase E1                                     0.32                            ND
      *lpdA*                   [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (1124206--1125628)   2-Oxoisovalerate dehydrogenase E3                                     0.34                            ND
      *serp2381*               [NC_002976.3](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976.3) (2428108--2431126)   NADH:flavin oxidoreductase/fumarate reductase, flavoprotein subunit   0.02                            0.082

qRT-PCR data are given as the means ± standard deviations of the results from three independent experiment. ND, not done.

Using KEGG analysis, the genes differentially expressed between the Δ*phoU2* mutant and the parent strain were involved not only in phosphate metabolism, bacterial growth, and biofilm formation but also in various pathways or processes, such as the pentose phosphate pathway, galactose metabolism, the TCA cycle, glycolysis and gluconeogenesis, respiratory chain reactions, ABC transporter activity, the phosphotransferase (PTS) system, the urea cycle, and ribosome protein production ([Table 2](#T2){ref-type="table"}).

To further determine the links between the DEGs and the biological behavior in the Δ*phoU2* mutant, a protein-protein interaction (PPI) network of DEGs based on the KEGG database (<http://www.genome.jp/kegg/pathway.html>) was constructed using Cytoscape software. The proteins encoded by DEGs were pooled with 174 proteins involved in various metabolic pathways. The expression of genes for proteins involved in the pentose phosphate pathway, galactose metabolism, and amino acid synthesis and TCA cycle genes was downregulated ([Fig. 9](#F9){ref-type="fig"}). In the pentose phosphate pathway, NADP (NADPH) and pentose are important products. NADPH plays a crucial role in coping with oxidative stress ([@B24][@B25][@B29]). As pentose is utilized to synthesize DNA and RNA, the absence of DNA and RNA in the Δ*phoU2* mutant leads to bacterial growth retardation.

![Interaction networks between DEGs identified by transcriptome comparison. The proteins encoded by DEGs (red, green), which were identified by comparison (at 6 h) of the transcriptomes of the Δ*phoU2* mutant and the parent strain, were extracted to construct a protein-protein interaction network. The lines in the network represent protein-protein interactions, including binding/association, phosphorylation, activation, and inhibition. Proteins encoded by upregulated and downregulated DEGs are indicated in red and green, respectively.](zjb9990945940009){#F9}

Biological validation of genes differentially expressed between the Δ*phoU2* mutant and the parent strain. {#sec2-8}
----------------------------------------------------------------------------------------------------------

DEGs related to inorganic phosphate metabolism, ATP synthesis, and the pentose phosphate pathway were validated by the detection of intracellular polyP, ATP, and NADPH, respectively.

The expression of DEGs involved in inorganic phosphate metabolism, the *pst* operon, and *serp0317* was upregulated in the Δ*phoU2* mutant. Inorganic phosphate (P~i~) taken up from the environment is used in bacterial metabolism, and the redundant inorganic phosphate is stored as a high-molecular-weight inorganic polyphosphate (polyP) in bacterial cells. To investigate the effects of the Δ*phoU1* and Δ*phoU2* deletions on P~i~ removal, we evaluated the levels of intracellular polyP in bacterial cells using a DAPI (4′,6-diamidino-2-phenylindole)-based fluorescence approach. The results showed that Δ*phoU2* mutant cells accumulated higher levels of polyP (1.66-fold) than the parent strain (*P* \< 0.05), while the amount of intracellular polyP in the Δ*phoU1* mutant was similar to that in the parent strain ([Fig. 10A](#F10){ref-type="fig"}). The polyP content in the *phoU2*-complemented Δ*phoU2*/pCN51::*phoU2* strain was restored to that in the parent strain, whereas the transformation of plasmid pCN51 had no effect on polyP accumulation in the Δ*phoU2* mutant.

![Intracellular polyP, ATP, NADP, and NADPH in the Δ*phoU2* mutant. Bacteria were grown to exponential phase in TSB medium. PolyP was assessed by measuring the fluorescence emission of the DAPI-polyP complex at 550 nm. (A) The fluorescence (in arbitrary units \[AU\]) of the DAPI-polyP complex was measured at 550 nm to evaluate the amount of intracellular polyP. (B) The amount of ATP was determined by measuring the fluorescence emission of the ATP complex at 587 nm. Bacteria were grown to exponential phase in TSB medium (OD~600~ = 0.5). (C and D) The amounts of total NADP and NADPH were measured using an NADP/NADPH quantification kit (Sigma). The amounts of total NADP and NADPH were determined by measuring the absorbance of the NADPH complex at 450 nm. Data (means ± SDs) are from three independent experiments. \*\*, *P* \< 0.01; \*, *P* \< 0.05.](zjb9990945940010){#F10}

Since polyP in cells can be converted to ATP by phosphotransferases ([@B30]) and the transcription of ATP synthase was upregulated in the Δ*phoU2* mutant, we determined the intracellular ATP levels in the Δ*phoU2* mutant, the Δ*phoU1* mutant, and the parent strain using an ATP colorimetric/fluorometric assay kit (Sigma). The intracellular ATP level in the Δ*phoU2* mutant was 2.7-fold higher than that in the parent strain (*P* \< 0.01) and the Δ*phoU1* mutant ([Fig. 10B](#F10){ref-type="fig"}). The amount of ATP recovered from the complemented Δ*phoU2*/pCN51::*phoU2* strain was similar to that recovered from the parent strain.

The expression of genes involved in the pentose phosphate pathway was downregulated in the Δ*phoU2* mutant. Because most of the NADP was generated via PPP and intracellular NADPH, as a reduced form of NADP, plays a very important role in protecting against the toxicity of reactive oxygen species (ROS), intracellular NADPH levels in the Δ*phoU2* mutant, the Δ*phoU1* mutant, and the parent strain were determined using an NADP/NADPH quantification kit (Sigma). The total amount of NADP in the Δ*phoU2* mutant (*A*~450~, 1.041 ± 0.085) was significantly reduced compared with that in the parent strain (*A*~450~, 1.691 ± 0.103) (*P* \< 0.05) ([Fig. 10C](#F10){ref-type="fig"}), while the amount of NADPH in the Δ*phoU2* mutant (*A*~450~, 0.014 ± 0.001) was 3-fold lower than that in the parent strain (*A*~450~, 0.006 ± 0.001) (*P* \< 0.01) ([Fig. 10D](#F10){ref-type="fig"}). The amount of total NADP or NADPH in the *phoU2*-complemented Δ*phoU2*/pCN51::*phoU2* strain was restored to the level in the parent strain. The reduced content of NADPH in the Δ*phoU2* mutant compared with that in the parent strain may have led to the weakened capacity of the Δ*phoU2* mutant to withstand oxidative stress. Then, the effects of *phoU2* on the bacterial response to H~2~O~2~ were investigated. SDS was also determined to be another stress control. Different concentrations of the bacterial culture were spotted onto TSA containing 6 mM H~2~O~2~ or 0.006% SDS ([@B8], [@B31]). The Δ*phoU2* mutant displayed higher sensitivity to H~2~O~2~, and no bacterial survival was detected when 6.4 × 10^5^ CFU was spotted onto plates containing 6 mM H~2~O~2~ ([Fig. 11A](#F11){ref-type="fig"}); bacteria of the parent strain were observed at 2.56 × 10^4^ CFU. Complementation of the Δ*phoU2* mutant could restore sensitivity to H~2~O~2~, the level of which reached that of the parent strain. However, the sensitivity of the Δ*phoU1* mutant to H~2~O~2~ was similar to that of the parent strain. Both the Δ*phoU1* mutant and the Δ*phoU2* mutant displayed a level of sensitivity to SDS similar to that of the parent strain ([Fig. 11B](#F11){ref-type="fig"}).

![Sensitivity of the Δ*phoU1* and Δ*phoU2* mutants to H~2~O~2~ and SDS. Overnight cultures of the bacterial strains were diluted 1:200 in fresh TSB medium and incubated at 37°C with aeration for 3 h until the OD~600~ was approximately 2. After 2-fold serial dilution, each 5-μl aliquot was spotted onto a TSB agar plate containing 6 mM H~2~O~2~ or 0.006% SDS and incubated overnight at 37°C. The growth of colonies on plates containing H~2~O~2~ or SDS was photographed.](zjb9990945940011){#F11}

DISCUSSION {#sec3}
==========

PhoU in E. coli has been identified to be a regulator of phosphate uptake ([@B32][@B33][@B34]). Increasing attention has been focused on the regulation of PhoU in bacterial drug tolerance and the stress response. On the basis of the conserved motif of the PhoU protein, two PhoU gene homologs (*serp0956* and *serp0316*) have been identified in S. epidermidis and named *phoU1* and *phoU2*, respectively. *phoU1* is located in the *pst* operon and shares a high degree of homology with *phoU* of E. coli. *phoU2* (*serp0316*) is cotranscribed with *serp0317* (see Fig. S1 in the supplemental material). *serp0317* is another inorganic phosphate transport gene with homology to *pit* in E. coli ([@B35], [@B36]). Using bioinformatics analysis, the genome of S. aureus (NCTC8325) was found to contain two PhoU gene homologs (*SAOUHSC_01384* and *SAOUHSC_00669*). *phoU2* of S. epidermidis shares 86% identity with *SAOUHSC_00669* at the nucleotide sequence level and PhoU2 shares 97% identity at the amino acid sequence level with SAOUHSC_00669 in S. aureus. *SAOUHSC_00669* has been investigated as a gene required for the sensitivity of an S. aureus strain with a point mutation in *pitA* (*SAOUHSC_00670*) to daptomycin ([@B11], [@B12]).

The number of PhoU homologs varies in different bacterial species. In E. coli, P. aeruginosa, and Streptococcus pneumoniae, there is only one PhoU, while in T. maritima, M. tuberculosis, M. marinum, S. aureus, and S. epidermidis, two PhoU homologs have been identified. In E. coli, *phoU* plays an important role in polyP accumulation ([@B34]) and the formation of multidrug-resistant bacteria ([@B5], [@B34]). In P. aeruginosa, PhoU is a negative regulator of intracellular ppGpp and polyP. However, *phoU* mutation has no effect on P. aeruginosa biofilm formation ([@B8]). In species of mycobacteria, there are two *phoU* homologs, *phoY1* and *phoY2. phoY2* has been investigated as the functional homolog of *phoU*, regulating the generation of multidrug-tolerant bacteria and maintaining metabolic homeostasis and adaptation to stress conditions in M. tuberculosis and M. marinum ([@B6], [@B7]).

Alignment of the amino acid sequences of PhoU1 and PhoU2 from S. epidermidis RP62A, PhoU from E. coli K-12, and the two PhoU homologs (PhoY1 and PhoY2) from M. tuberculosis H37Rv showed that the metal ion-binding sites are conserved in all the PhoU homologs (Fig. S2). To investigate the regulatory functions of the *phoU* homologs, the Δ*phoU1* and Δ*phoU2* mutants of the S. epidermidis 1457 strain were constructed and the transcriptomes of the deletion mutants and the parent strain were compared. We detected the transcription levels of *phoU1* (*SERP0956*) and *phoU2* (*SERP0316*) in SE1457 by RT-qPCR at different time point (4 h, 6 h, 8 h, 10 h, and 12 h), and both *phoU1* and *phoU2* of SE1457 were expressed at the time points evaluated (Fig. S1). In logarithmic phase (6 h), 945 genes were differentially expressed between the Δ*phoU2* mutant and the parent strain; among these, 474 were upregulated and 471 were downregulated. However, only 92 DEGs were detected between Δ*phoU1* and the parent strain during logarithmic phase and 2 DEGs were detected during stationary phase. On the basis of Gene Ontology analysis of the genes differentially expressed between the Δ*phoU1* mutant and the parent strain, 23 DEGs that were downregulated in the Δ*phoU1* mutant were involved in translation, ribosomal structure, and biogenesis, while 69 upregulated DEGs were involved in 17 pathways or metabolic processes. However, the differences in the levels of expression of none of these DEGs were statistically significant (*P* \> 0.05). It is worth mentioning that the *pst* operon was not identified among the genes differentially expressed between the Δ*phoU1* mutant and the parent strain, and the results were validated by RT-qPCR. Hence, in this study, we focused on investigating *phoU2* functions in S. epidermidis.

The Δ*phoU2* mutant of S. epidermidis displayed growth retardation under both microaerobic and oxic conditions, in accordance with the findings in an E. coli strain with a PhoU deletion ([@B37]). The deletion of *phoU1* had no effect on bacterial growth. Analysis of the DEGs (genes differentially expressed between the Δ*phoU2* mutant and the parent strain) showed that in the Δ*phoU2* mutant, the expression of *pflA* and *nrdDG* was downregulated. These genes are involved in the growth of S. epidermidis under microaerobic conditions. PflA is an enzyme activating PflB, a pyruvate formate-lyase that catalyzes the reversible conversion of pyruvate to formate, thereby producing acetyl coenzyme A. Thus, PflA plays an important role in utilization of the energy supply when pyruvate is available and favors the growth of cells under fermentation conditions ([@B18]). The protein encoded by *nrdDG* is a class III ribonucleotide reductase that catalyzes the synthesis of deoxynucleoside triphosphates (dNTPs) via the reduction of nucleoside triphosphates under anaerobic conditions ([@B38][@B39][@B40]). In the Δ*phoU2* mutant, the expression of *yycFG* is significantly downregulated (*P* \< 0.01); *yycFG* is an essential two-component system in Gram-positive bacteria that regulates cell wall metabolism, cell division, virulence, and biofilm formation ([@B41], [@B42]). Expression of the essential two-component system *yycFG* was downregulated during the logarithmic phase but was not detected during the stationary phase. This finding is in accordance with the results of the assessments of the Δ*phoU2* mutant under the different growth conditions. In addition, the downregulated expression of DEGs involved in the TCA cycle, glycolysis and gluconeogenesis, and the pentose phosphate pathway may promote growth retardation ([Fig. 12](#F12){ref-type="fig"} and [Table 3](#T3){ref-type="table"}). The growth retardation of the Δ*phoU2* mutant did not persist to stationary phase, as there were no differences in the CFU counts from those of the parent strain in stationary phase.

![Major metabolic pathways in the Δ*phoU2* mutant revealed by DEGs. Shown are transcription of enzyme-encoding genes that were downregulated and upregulated, enzyme-encoding genes that were not found in DEGs (genes differentially expressed between the Δ*phoU2* mutant and the parent strain), stimulatory reactions, prohibitory reactions, reversible reaction interactions between the two products, and products whose amounts were increased or decreased. The numbers represent the enzyme-encoding genes listed in [Table 3](#T3){ref-type="table"}. P, phosphate; CoA, coenzyme A.](zjb9990945940012){#F12}

###### 

DEGs involved in major metabolic pathway

  DEG no.   Gene name(s)                                 Enzyme(s) encoded
  --------- -------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------
  1         *lacA*, *lacD*, *lacG*                       Galactose-6-phosphate isomerase subunit LacA, tagatose-1,6-diphosphate aldolase, 6-phospho-beta-galactosidase
  2         *galU*                                       UTP-glucose-1-phosphate uridylyltransferase
  3         *serp2055*                                   Phosphoglucomutase/phosphomannomutase
  4         *gntK*                                       Gluconokinase
  5         *pgi*                                        Glucose-6-phosphate isomerase
  6         *fruK*                                       1-Phosphofructokinase
  7         *fbaA*                                       Fructose-bisphosphate aldolase
  8         *gapA2*, *pgk*, *gpmA*                       Glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglyceromutase
  9         *serp0856*, *serp0857*                       2-Oxoglutarate ferredoxin oxidoreductase subunit beta, pyruvate ferredoxin oxidoreductase, alpha subunit
  10        *acnA*                                       Aconitate hydratase
  11        *acnA*                                       Aconitate hydratase
  12        *icd*                                        Isocitrate dehydrogenase
  13        *serp2324*                                   Branched-chain alpha-keto acid dehydrogenase subunit E2
  14        *sucC*                                       Succinyl coenzyme A synthetase subunit beta
  15        *sdhA*, *sdhB*                               Succinate dehydrogenase iron-sulfur subunit, succinate dehydrogenase flavoprotein subunit
  16        *fumC*                                       Fumarate hydratase
  17        *mqo-1*, *mqo-3*                             Malate:quinone oxidoreductase, malate:quinone oxidoreductase
  18        *serp1076*, *serp1077*, *serp1078*, *lpdA*   2-Oxoisovalerate dehydrogenase E2, 2-oxoisovalerate dehydrogenase E1, 2-oxoisovalerate dehydrogenase E1, 2-oxoisovalerate dehydrogenase E3
  19        *zwf-2*                                      Glucose-6-phosphate 1-dehydrogenase
  20        *rpe*                                        Ribulose-phosphate 3-epimerase
  21        *deoB*                                       Phosphopentomutase
  22        *deoC*                                       Deoxyribose-phosphate aldolase
  23        *prsA*                                       Ribose-phosphate pyrophosphokinase
  24        *xylB*                                       [d]{.smallcaps}-Xylulose kinase
  25        *tkt*                                        Transketolase

S. epidermidis is an important nosocomial pathogen that forms biofilms on implanted medical devices. We studied the regulatory role of *phoU2* in this respect. The Δ*phoU2* mutant exhibited impaired biofilm formation under both static and hydrodynamic conditions, in contrast to the findings obtained for P. aeruginosa. A study performed in 2015 found that inactivation of *phoU* had no effect on the formation of bacterial biofilms in P. aeruginosa ([@B8]). In the Δ*phoU2* mutant, the expression of the sigma factor B regulator gene (*rsbU*), involved in biofilm formation, is downregulated (*P* \< 0.01) ([@B20]). In addition, the downregulation of genes that participate in galactose metabolism plays an essential role in Bacillus subtilis biofilm formation. The intermediate product of galactose metabolism, UDP-galactose, is used in the synthesis of exopolysaccharide (EPS) of the biofilm matrix in B. subtilis ([@B43]). In accordance with these phenomena, the production of Aap was decreased in the Δ*phoU2* mutant. Defective attachment of the Δ*phoU2* mutant could be another important reason for the reduced biofilm formation. The decreased biofilm formation was not due to growth retardation, as the number of CFU of the Δ*phoU2* mutant during the stationary phase was similar to that of the parent strain, and the time required for biofilm formation was extended to 48 h.

The downregulated expression of genes involved in the TCA cycle, glycolysis, and gluconeogenesis resulted in a lack of polysaccharide, which was also responsible for the biofilm formation defect in the Δ*phoU2* mutant.

The Δ*phoU2* mutant of S. epidermidis displayed a rough cell wall and rapid autolysis. The rough cell wall may indicate that the cell wall of the Δ*phoU2* mutant was incomplete, potentially due to the low expression levels of the galactose metabolism genes. The intermediate products of galactose metabolism are involved in the synthesis of peptidoglycan. Peptidoglycan, which is also known as murein, is the most important component of Gram-positive bacterial cell walls ([Fig. 12](#F12){ref-type="fig"}). In addition to the autolysis genes, *ssaA* and *serp0318* were upregulated in the Δ*phoU2* mutant; the incomplete cell wall may have led to the rapid autolysis in the Δ*phoU2* mutant ([@B22], [@B23]). Besides the peptidoglycan, the level of another component of the cell wall, teichoic acid, may also have been decreased in the Δ*phoU2* mutant. Teichoic acids are special components in the cell wall of most Gram-positive bacteria, such as species in the genera Staphylococcus, Streptococcus, and Bacillus. Teichoic acids are bacterial copolymers of glycerol phosphate or ribitol phosphate and carbohydrates linked via phosphodiester bonds and are the essential product of glycolysis or the pentose phosphate pathway. The downregulation of glycolysis or the pentose phosphate pathway in the Δ*phoU2* mutant may reduce the level of production of teichoic acids, which would result in a rough cell surface and an increase in autolysis capacity ([@B44], [@B45]).

Inorganic phosphate (P~i~) is an important macronutrient for all living organisms, comprising up to 3% of the bacterial dry weight, and is involved in many important pathways ([@B8]). The expression of genes in the *pst* operon and *serp0317* was upregulated in the Δ*phoU2* mutant, which is consistent with the intracellular accumulation of polyP in the Δ*phoU2* mutant. A portion of the inorganic phosphate taken up from the environment was used for bacterial metabolism, and redundant inorganic phosphate was stored as high-molecular-weight inorganic polyphosphate (polyP) in bacterial cells ([@B46]) ([Fig. 12](#F12){ref-type="fig"}). PolyP is a linear polymer composed of several molecules of orthophosphate (P~i~) that are linked by energy-rich phosphoanhydride bonds ([@B30]). PolyP is a known stress response molecule that accumulates in microorganisms in response to nutrient deprivation, high salt concentrations, or other environmental stress conditions ([@B30], [@B47]). An imbalance in the amount of intracellular polyP in E. coli elicits a defective response to oxidative, osmotic, and thermal stresses ([@B5], [@B34]). In M. tuberculosis, a *phoY2* transposon insertion mutant accumulates large amounts of polyP and has an increased sensitivity to thermal stress, H~2~O~2~, and antibiotics ([@B6], [@B7]). The characteristics of phosphate metabolism in the S. epidermidis Δ*phoU2* mutant are similar to those in *phoU* deletion mutants or insertion inactivation mutants of E. coli, P. aeruginosa, M. tuberculosis, and M. marinum ([@B5][@B6][@B8]).

To study the regulation of phosphate metabolism by PhoU1 and PhoU2, we determined the intracellular inorganic phosphate content and the growth of the PhoU mutants (the Δ*phoU1* and Δ*phoU2* mutants), in addition to the amount of polyP, under phosphate-limiting conditions. There were no differences in the intracellular inorganic phosphate content between the PhoU mutants and the parent strain (SE1457) (Fig. S3B). The growth curves of the PhoU mutants under P~i~-limiting conditions were similar to those of the mutants cultured in TSB medium (P~i~-replete conditions) (Fig. S3A). Comparison of the transcriptomes of the PhoU mutants and the parent strain showed that the transcription of the *pst* operon was upregulated in the Δ*phoU2* mutant, which suggests that phosphate uptake was increased in the Δ*phoU2* mutant and the extra phosphate was utilized to synthesize polyP to maintain the intracellular inorganic phosphate at a level similar to that in SE1457. However, in the Δ*phoU1* mutant there was no difference in the level of *pst* operon expression, the intracellular inorganic phosphate and polyP content, or growth under P~i~-limiting conditions compared with the findings for SE1457. These results suggest that PhoU2 but not PhoU1 plays an important role in the homeostasis of intracellular Pi.

The polyP in bacterial cells could be converted to ATP by phosphotransferases. In addition, among the genes differentially expressed between the Δ*phoU2* mutant and the parent strain, the expression of genes encoding ATP synthase was upregulated. Thus, we verified that the levels of intracellular ATP were higher in the Δ*phoU2* mutant strain than the parent strain, which is consistent with the results obtained for M. marinum ([@B7]). ATP is the most important energy-providing substrate. A high level of intracellular ATP influences the expression of many genes and metabolic pathways, such as the genes for ATP-binding cassette (ABC) transporters. ABC transporters utilize the energy from ATP binding and hydrolysis to transport various substrates, including ions, amino acids, peptides, sugars, and other molecules, across cellular membranes ([@B48]). Excessive ABC transporter activity would result in an imbalance in the uptake of substances. A high level of ATP would maintain cellular metabolism at an unhealthy active level ([@B49]). Under this condition, bacteria are easily killed by bactericidal antibiotics. Therefore, S. epidermidis Δ*phoU2* showed a reduced drug tolerance compared with the wild-type strain ([Fig. 12](#F12){ref-type="fig"}).

On the basis of the protein-protein interaction network developed for the proteins encoded by the DEGs, 174 proteins encoded by DEGs were found to be involved in various metabolic pathways, such as the pentose phosphate pathway, the TCA cycle, and galactose metabolism. Among these, the expression of all genes that participate in the pentose phosphate pathway was downregulated in the Δ*phoU2* mutant. We found that the amount of NADPH in the Δ*phoU2* mutant decreased 3-fold compared with that in the parent strain. NADPH is produced mainly via the pentose phosphate pathway, which parallels the glycolysis pathway. The pentose phosphate pathway generates NADPH and pentoses (5-carbon sugars) as well as ribose-5-phosphate. NADPH provides the reducing equivalents for biosynthetic reactions and the oxidation-reduction involved in protection against the toxicity of reactive oxygen species (ROS), allowing the regeneration of glutathione (GSH) ([@B24][@B25][@B29]). The decreased NADPH in the Δ*phoU2* mutant corresponded to its high sensitivity to H~2~O~2~ ([Fig. 12](#F12){ref-type="fig"}). The major product of PPP is ribose-5-phosphate, a precursor for the synthesis of nucleotides (DNA and RNA). The reduced synthesis of ribose-5-phosphate led to a lack of DNA and RNA, and this reduced amount of ribose-5-phosphate might be responsible for the growth retardation seen in the Δ*phoU2* mutant ([Fig. 12](#F12){ref-type="fig"}).

To confirm the role of *phoU2* on the regulation of growth and biofilm formation in SE1457, we used the antisense technology to test the effect of silencing of *phoU2* expression on the Δ*phoU1* mutant. First, we constructed a plasmid which could express *phoU2* antisense RNA (AS-*phoU2*) in the presence of 250 ng/ml anhydrotetracycline (ATc), and the plasmid was transferred to the Δ*phoU1* mutant to obtain the AS-*phoU2* Δ*phoU1* mutant. After induction with ATc, the transcription level of *phoU2* was reduced to 10% in the AS-*phoU2* Δ*phoU1* mutant compared with that in the Δ*phoU1* mutant. The AS-*phoU2* Δ*phoU1* mutant displayed a level of growth retardation that was the same as that in the Δ*phoU2* mutant (Fig. S4A), while the level of biofilm formation was less than that in the Δ*phoU1* mutant carrying the vector pMX6 (*P* \< 0.01) (Fig. S4B).

In summary, *phoU2* regulates growth, biofilm formation, oxidative stress, and drug tolerance via some important pathways and processes, including the pentose phosphate pathway, glycolysis, the TCA cycle, inorganic phosphate metabolism, galactose metabolism, and ABC transporter activity in SE1457. However, no obvious phenotype of the Δ*phoU1* mutant was observed in the presence of *phoU2* in SE1457. The mechanism of *phoU2* regulation and the interaction between *phoU1* and *phoU2* in SE1457 warrant further investigation.

The effects of PhoU1 and PhoU2 on biofilm formation and antibiotic tolerance in S. epidermidis clinical strains need to be further studied by the use of gene knockout or antisense RNA technology.

MATERIALS AND METHODS {#sec4}
=====================

Bacterial strains, plasmids, growth conditions, and chemicals. {#sec4-1}
--------------------------------------------------------------

All of the bacterial strains and plasmids used in the study are shown in [Table 4](#T4){ref-type="table"}. The biofilm-positive strain S. epidermidis ATCC 35984 (RP62A; GenBank accession number [NC_002976](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976)) and non-biofilm-forming strain ATCC 12228 (GenBank accession number [NC_004461](https://www.ncbi.nlm.nih.gov/nuccore/NC_004461)) were purchased from the American Type Culture Collection (ATCC; Manassas, VA) ([@B50]). S. epidermidis 1457 (SE1457) and S. aureus RN4220 were provided by Gao Fu from the University of Hong Kong. The S. epidermidis strains and S. aureus RN4220 were cultured in tryptic soya broth (TSB; Oxoid, Basingstoke, UK) at 37°C with shaking at 220 rpm. Glucose was added to the TSB medium at a concentration of 0.5% for the detection of biofilm formation. Electroporation was used for plasmid transformation, and B2 medium (1% casein hydrolysate, 2.5% yeast extract, 0.5% glucose, 2.5% NaCl, 0.1% K~2~HPO~4~, pH 7.5) was used for the recovery of bacteria. The antibiotics used in this study were purchased from Sigma Chemical Co. (Los Angeles, CA, USA) and used at concentrations of 10 mg/liter for chloramphenicol, 100 mg/liter for ampicillin, 50 ng/ml for anhydrotetracycline, and 10 mg/liter for erythromycin.

###### 

Bacterial strains and plasmids used in the present study

  Bacterial strain or plasmid     Description                                                                                                                                                Source
  ------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------
  Bacterial strains                                                                                                                                                                          
      S. epidermidis 1457         Clinical strain, biofilm positive                                                                                                                          
      Δ*phoU1* mutant             *phoU1* deletion mutant obtained using SE1457 as the parent strain                                                                                         This study
      Δ*phoU2* mutant             *phoU2* deletion mutant obtained using SE1457 as the parent strain                                                                                         This study
      Δ*phoU2*/pCN51::*phoU2*     *phoU2* mutant complemented with plasmid pCN51 harboring the *phoU2* gene                                                                                  This study
      Δ*phoU2*/pCN51              *phoU2* mutant complemented with plasmid pCN51                                                                                                             This study
      S. epidermidis RP62A        Standard strain, biofilm positive                                                                                                                          ATCC
      S. epidermidis ATCC 12228   Standard strain, biofilm negative                                                                                                                          ATCC
      S. aureus RN4220            Restriction-deficient strain permitting shuttle of a plasmid modified by its host specificity determination from Gram-negative to Gram-positive bacteria   Gao Fu, University of Hong Kong
  Plasmids                                                                                                                                                                                   
      pKOR1                       Temp-sensitive E. coli (Amp^r^)-Staphylococcus (Cm^r^) shuttle vector                                                                                      Li Min, Institute of Antibiotics, Huashan Hospital
      pKOR1-Δ*phoU1*              Recombinant plasmid                                                                                                                                        This study
      pKOR1-Δ*phoU2*              Recombinant plasmid                                                                                                                                        This study
      pCN51                       A Cd^2+^-inducible shuttle plasmid, Erm^r^                                                                                                                 Wageningen University, Holland
      pCN51- *phoU*2              A Cd^2+^-inducible shuttle plasmid, Erm^r^; the *phoU*2 gene was cloned into plasmid pCN51                                                                 This study

Construction of Δ*phoU1* and Δ*phoU2* mutants and complemented strains. {#sec4-2}
-----------------------------------------------------------------------

The *phoU1* and *phoU2* deletion mutants of the SE1457 strain were constructed by allelic replacement using the temperature-sensitive plasmid pKOR1 as described by Bae and Schneewind ([@B51]). Briefly, the upstream and downstream fragments of *phoU1* and *phoU2* were amplified by PCR and separately cloned into the pKOR1 vector, resulting in pKOR1-Δ*phoU1* and pKOR1-Δ*phoU2*. The recombinant plasmid pKOR1-Δ*phoU* was successively transferred into E. coli DH5α, S. aureus RN4220, and then SE1457, followed by allelic replacement as described previously ([@B52], [@B53]). The *phoU1*and *phoU2* deletion mutants were verified by PCR, RT-qPCR, and direct sequencing and are referred to as the Δ*phoU1* and Δ*phoU2* mutants. The complemented Δ*phoU2* mutant strain was constructed using a shuttle vector, pCN51 ([@B54]). The *phoU2* gene and its Shine-Dalgarno region were amplified by PCR using primers *phoU2*-BamHI-F/*phoU2*-KpnI-R, whose sequences are provided in [Table 5](#T5){ref-type="table"}. Plasmid pCN51-*phoU2* was used for complementation and was constructed by inserting a fragment of the digested PCR products of the *phoU2* gene with BamHI and KpnI ([@B55]). Plasmid pCN51-*phoU2* was transformed by electroporation into the Δ*phoU2* mutant, forming the complemented Δ*phoU2*/pCN51::*phoU2* strain. The Δ*phoU2* strain containing the empty vector pCN51 was designated the Δ*phoU2*/pCN51 mutant. The primers used in this assay are listed in [Table 5](#T5){ref-type="table"}.

###### 

Primers used in this study

  Primer use and primer[^*a*^](#T5F1){ref-type="table-fn"}   Primer sequence (5′--3′)                                    Location[^*b*^](#T5F2){ref-type="table-fn"}   Size of PCR product (bp)   Note[^*c*^](#T5F3){ref-type="table-fn"}
  ---------------------------------------------------------- ----------------------------------------------------------- --------------------------------------------- -------------------------- -----------------------------------------
  Construction of Δ*phoU1* mutant                                                                                                                                                                 
      *phoU1* us-F                                           [GGGGACAAGTTTGTACAAAAAAGCAGGCT]{.ul}AAATGCCTCAAGCAGAATTC    974705--974724                                1,061                      *attB1*
      *phoU1*us-R                                            GG[GGTACC]{.ul}AATTGCCATTGCATCTTATCC                        973625--973645                                                           KpnI
      *phoU1*ds-F                                            GG[GGTACC]{.ul}GATTAAATTATCAAATCC TATTG                     972969--972991                                823                        KpnI
      *phoU1*ds-R                                            [GGGGACCACTTTGTACAAGAAAGCTGGGT]{.ul}TTGCTCAGAATAAAGGAAAAG   972127--972147                                                           *attB2*
  Construction of Δ*phoU*2 mutant                                                                                                                                                                 
      *phoU2* us-F                                           [GGGGACAAGTTTGTACAAAAAAGCAGGCT]{.ul}GTTGATCGTGGTAGACCG      319402--319419                                1,100                      *attB1*
      *phoU2* us-R                                           GG[GGTACC]{.ul}CATTAAAAATCC TCCATTTTGA                      320480--320501                                                           KpnI
      *phoU2* ds-F                                           GG[GGTACC]{.ul}TAAGGGAGTCTTTATTTATGTC                       321114--321135                                959                        KpnI
      *phoU2* ds-R                                           [GGGGACCACTTTGTACAAGAAAGCTGGGT]{.ul}CACCCATGTTACAACCATAC    322053--322072                                                           *attB2*
  Construction of Δ*phoU2* complemented strain                                                                                                                                                    
      *phoU2*-BamHI-F                                        CGC[GGATCC]{.ul}GTAAATCAGTTCCTCA                                                                                                     BamHI
      *phoU2*-KpnI-R                                         CGG[GGTACC]{.ul}TAAATAAAGACTCCCT                                                                                                     KpnI
  RT-qPCR                                                                                                                                                                                         
      *gyrB* F                                               AGAAGAGGAAGTTAGAGAAGA                                       2611073--2611093                              168                        
      *gyrB* R                                               GCATATCC ACTGTTATATTGAAG                                    2610926--2610948                                                         
      *phoU1* F                                              CGTCTTGGTCTTCGTGTA                                          973556--973573                                169                        
      *phoU1* R                                              CAATAGGTTGTTGTCTCGTAAT                                      973405--973426                                                           
      *phoU2* F                                              GCTGTAGGATTACTTGTAGAC                                       320874--320894                                200                        
      *phoU2* R                                              GCTTGACACTTATCTGCTATT                                       321073--321053                                                           

Primers were designed according to the genomic sequence of S. epidermidis RP62A (GenBank accession number [NC_002976](https://www.ncbi.nlm.nih.gov/nuccore/NC_002976)). F, forward primer; R, reverse primer.

Location of the primer in the genomic sequence of S. epidermidis RP62A.

The underlined sequences represent the BP reaction sites or restriction enzyme sites.

Growth curves of the Δ*phoU1* and the Δ*phoU2* mutant strains. {#sec4-3}
--------------------------------------------------------------

The SE1457, Δ*phoU1*, Δ*phoU2*, Δ*phoU2*/pCN51::*phoU2*, and Δ*phoU2*/pCN51 strains were cultured in TSB at 37°C with shaking for 12 h. Overnight cultures of the S. epidermidis strains were diluted (1:200) in 10 ml TSB in a 100-ml flask and incubated at 37°C under aerobic or microanaerobic conditions with shaking at 220 rpm. The OD~600~ was measured using a UV spectrophotometer (Eppendorf, Hamburg, Germany) ([@B53]).

Morphology of the Δ*phoU1* and Δ*phoU2* mutants observed by TEM. {#sec4-4}
----------------------------------------------------------------

The SE1457, Δ*phoU1*, Δ*phoU2*, Δ*phoU2*/pCN51::*phoU2*, and Δ*phoU2*/pCN51 strains were cultured in TSB at 37°C for 6 h. The log-phase bacteria were rinsed with phosphate-buffered saline (PBS), prefixed with 2.5% glutaraldehyde at 4°C for 2 h, and then fixed in 1% osmium for 3 h. The fixed samples were dehydrated in a graded ethanol series, embedded in epoxy resin, and stained with uranyl acetate and lead citrate. Ultrathin sections were cut with a Leica Ultracut microtome and observed under a transmission electron microscope (TEM; Philips Tecnai-12 Biotwin). TEM micrographs were separately obtained at magnifications of ×11,500 and ×26,500 ([@B56], [@B57]).

Microtiter plate assay of biofilm formation. {#sec4-5}
--------------------------------------------

The biofilm-forming ability of the strains was assessed using a semiquantitative microtiter plate assay, based on the protocol described by Christensen et al. ([@B58]). Briefly, overnight cultures of the S. epidermidis strains were diluted (1:200) into fresh TSB (containing 0.5% glucose). Aliquots of the diluted cultures were inoculated into polystyrene 96-well flat-bottomed microtiter plates (Costar; Corning, USA) and incubated at 37°C for 6 h, 12 h, 24 h, or 48 h. After the planktonic cultures were decanted, the plates were gently rinsed three times with PBS. The biofilms were fixed with 99% methyl alcohol for 15 min, stained with 2% crystal violet for 5 min, rinsed with running tap water, and air dried at room temperature. The optical densities at 570 nm (OD~570~s) of the plates were then determined using a spectrophotometer (DTX880; Beckman Coulter, Fullerton, CA) ([@B52]). The biofilm formation by each strain was assessed three times using strains ATCC 12228 and ATCC 35984 as non-biofilm-forming and biofilm-forming controls, respectively.

CLSM of biofilms. {#sec4-6}
-----------------

An overnight culture of each S. epidermidis strain (1:200 dilution) was inoculated into 2 ml TSB (with 0.5% glucose supplementation) in a cell culture dish containing a glass coverslip (World Precision Instruments, USA) ([@B59], [@B60]). After culturing under static conditions at 37°C for 24 h, the dish was gently washed three times with saline and then stained with LIVE/DEAD reagents (1 μM SYTO9 and 1 μM propidium iodide \[PI\]; Thermo Fisher Scientific, Houston, TX) for 20 min and observed using a confocal laser scanning microscope (CLSM; TCS-SP5, Leica, Germany) with a 63× oil immersion objective (numerical aperture, 1.4). Photomicrographs of the biofilms were generated using Leica LAS AF software. Three-dimensional images were created using IMARIS (version 7.0.0) software (Bitplane). The live and dead bacteria were quantified using ImageJ software. Three independent experiments were performed.

Flow-based biofilm assays. {#sec4-7}
--------------------------

A BioFlux 1000 system (Fluxion Biosciences) with a Leica microscope and temperature-controlled housing was used for all imaging experiments. Automated microscopy and image processing were performed using BioFlux Montage software. BioFlux 48-well plates (catalog no. 910-0047; Fluxion Biosciences) allowing up to 24 individual treatment conditions were primed with TSB from the inlet well at a shear setting of 2 dynes/cm^2^ for 10 min. Cultures of S. epidermidis were grown to mid-log phase and normalized to an OD~600~ of 0.15. Bacteria were seeded from the outlet well into the channel and viewing window at a shear setting of 2 dynes/cm^2^ for 3 s. After 1 h of incubation at 37°C, TSB was set to flow from the inlet well at a shear setting of 0.15 dyne/cm^2^ for the duration of the experiment. Images were automatically acquired every 10 min at multiple stage positions using bright-field illumination; images were also acquired in the red channel (tetramethyl rhodamine isothiocyanate \[TRITC\] filter set; catalog no. 86013v2; Chroma, Bellows Falls, VT) using a 200-ms exposure time. The background-corrected average pixel intensity per image was used to quantify biofilm formation ([@B61]).

Autolysis of the Δ*phoU1* and Δ*phoU2* mutants induced by Triton X-100. {#sec4-8}
-----------------------------------------------------------------------

Autolysis assays were performed as described by Brunskill and Bayles with minor modifications ([@B62]). Briefly, the S. epidermidis strains were cultured in TSB (containing 1 M NaCl) to mid-exponential phase (6 h) and harvested by centrifugation (4,000 × *g*, 4°C, 15 min). After the bacterial pellets were washed with ice-cold water, they were resuspended to an OD~600~ of 1.0 in lysis buffer (50 mM Tris-HCl buffer, pH 8.0, containing 0.05% Triton X-100) and incubated at 30°C with shaking at 200 rpm. The optical density at 600 nm was measured at 30-min intervals for 3 h ([@B59]).

Initial adherence capacity of the Δ*phoU1* and Δ*phoU2* mutants. {#sec4-9}
----------------------------------------------------------------

Primary attachment of the Δ*phoU1* and Δ*phoU2* strains to a polystyrene surface was assessed as described previously, with modifications ([@B52], [@B53], [@B59]). Briefly, overnight cultures of the SE1457, Δ*phoU1*, Δ*phoU2*, Δ*phoU2*/pCN51::*phoU2*, and Δ*phoU2*/pCN51 strains were inoculated into TSB and cultured at 37°C to logarithmic phase (OD~600~, ≈0.6). The bacterial culture was adjusted to an OD~600~ of 0.1 with PBS and inoculated into six-well plates (2 ml/well; Nunc, Roskilde, Denmark). After incubation at 37°C for 2 h, the plates were washed gently with PBS and observed under a microscope using a 40-fold objective lens. The numbers of attached cells in each photomicrograph were counted using ImageJ software, and three microscopic fields were observed per sample.

Assay of PIA in biofilms. {#sec4-10}
-------------------------

Polysaccharide intercellular adhesion (PIA) in the biofilms of the Δ*phoU1* and Δ*phoU2* mutants was semiquantified by a dot blot assay with a wheat germ agglutinin (WGA)-horseradish peroxidase (HRP) conjugate as described previously ([@B63], [@B64]). Briefly, overnight cultures of the S. epidermidis strains were inoculated into six-well plates (Nunc) and incubated at 37°C for 24 h. Biofilms were scraped off the bottoms of the wells, resuspended in 0.5 M EDTA, and centrifuged (13,000 × *g*, 5 min) after they were heated at 100°C for 5 min. The supernatant was treated with proteinase K (20 mg/ml) at 37°C for 3 h and inactivated at 100°C for 5 min. Serial dilutions of the PIA assay extract were transferred to a nitrocellulose membrane (Millipore, Billerica, MA) using a 96-well dot blot device (Biometra GmbH, Gottingen, Germany). The air-dried membrane was blocked with 5% (wt/vol) skim milk and subsequently incubated with the WGA (3.2 μg/ml)-HRP conjugate for 1 h (Lectinotest Laboratory, Lviv, Ukraine). HRP activity was visualized by chromogenic detection using 4-chloride-1-naphthol (Sigma) as the substrate. Quantitation of PIA was represented as the highest dilution of the supernatant in which HRP was detectable.

Detection of Aap. {#sec4-11}
-----------------

Accumulation-associated protein (Aap) expression by the Δ*phoU1* and Δ*phoU2* strains was determined by Western blotting with an Aap-specific monoclonal antibody (MAb~18B6~) that was generated in our laboratory ([@B60]). Briefly, 24-h-old biofilms of the S. epidermidis strains were collected and adjusted to an identical OD~600~ after they were washed with PBS. The bacteria were treated with lysostaphin (Sigma) and centrifuged (20,000 × *g*) at 4°C for 30 min. The supernatants were separated using SDS-PAGE (7%) and blotted onto a polyvinylidene fluoride membrane (pore size, 0.45 μm; Millipore) by electrotransfer. The membrane was incubated with MAb~18B6~ (10 ng/ml) and then with goat anti-mouse IgG conjugated to HRP (Santa Cruz, Santa Cruz, CA), followed by visualization using an enhanced chemiluminescence (ECL) Western blotting system (Thermo Fisher Scientific, Waltham, MA).

Quantification of eDNA. {#sec4-12}
-----------------------

The isolation of extracellular DNA (eDNA) from the biofilms was performed as described previously ([@B52], [@B53]). Briefly, 24-h-old biofilms cultured in a 96-well polystyrene plate were chilled at 4°C for 1 h, and EDTA was added at a final concentration of 2.5 mM. After measurement of the OD~600~ of the unwashed biofilm (biofilm biomass), eDNA extraction solution (50 mM Tris-HCl, 10 mM ETDA, 500 mM NaCl, pH 8.0) was added to the wells. The biofilms were scraped off and centrifuged (13,000 × *g*) for 5 min at 4°C. The eDNA in the supernatant was extracted with phenol-chloroform-isoamyl alcohol (25:24:1), precipitated with 100% alcohol, and resuspended in Tris-EDTA buffer. The amount of eDNA was quantified by qPCR with SYBR Premix *Ex Taq* (TaKaRa Bio, Inc., Shiga, Japan) using the primers specific for *gyrB* (gyrase B gene), *serp0306* (ferrichrome transport ATP-binding protein A gene), *leuA* (2-isopropylmalateynthase gene), and *lysA* (diaminopimelate decarboxylase A gene). Each gene was assayed in the qPCR in triplicate in three independent experiments. Relative quantitation of the eDNA in each sample was calculated as the total amount of eDNA (in nanograms) divided by the biofilm biomass (OD~600~).

Measurement of intracellular polyP in the Δ*phoU1* and Δ*phoU2* mutants. {#sec4-13}
------------------------------------------------------------------------

A DAPI (4′,6-diamidino-2-phenylindole)-based fluorescence approach was used to evaluate the amount of intracellular polyP in the S. epidermidis cell suspensions as described previously ([@B65]). Logarithmic-phase cultures of the S. epidermidis strains grown in TSB were collected by centrifugation at 4,000 × *g* for 5 min at room temperature. The pellets were washed three times with 100 mM Tris-HCl (pH 7.4) and resuspended in the same buffer to an OD~600~ of 0.2. DAPI (Beyotime) was added to a final concentration of 10 μM. The DAPI fluorescence spectra (excitation, 415 nm; emission, 450 to 650 nm) were recorded using a Cary Eclipse fluorescence spectrophotometer (Varian) after 5 min of agitation at room temperature in the dark. The fluorescence (in arbitrary units) of the DAPI-polyP complex was measured at 550 nm for evaluation of the amount of intracellular polyP.

Detection of intracellular ATP in the Δ*phoU1* and Δ*phoU2* mutants. {#sec4-14}
--------------------------------------------------------------------

The intracellular ATP levels in the Δ*phoU1* and Δ*phoU2* mutants were detected using an ATP colorimetric/fluorometric assay kit (catalog no. MAK190) from Sigma with modification for S. epidermidis. At the time points indicated above and in the relevant figures (when the OD~600~ was 0.5), the cells were pelleted by centrifugation at 4,000 × *g* at 4°C, washed with cold sterile PBS, resuspended in 1 ml of ATP extraction buffer within 10 min of initial pelleting of the culture, and lysed with 0.1 mm glass-silica beads in a BeadBeater apparatus (BioSpec). The resulting supernatant, obtained by centrifuging the samples at 20,000 × *g* for 15 min at 4°C, was filtered through a 10-kDa-cutoff filter, as suggested by the assay manufacturer, to remove enzymes that could otherwise deplete ATP.

Quantification of intracellular NADP^+^/NADPH in the Δ*phoU1* and Δ*phoU2* mutants. {#sec4-15}
-----------------------------------------------------------------------------------

NADP^+^ and NADPH were quantified as described by Posada et al. using an NADPH/NADP^+^ kit from Sigma, which was modified for S. epidermidis ([@B66]). Because NADPH can be unstable, the cells were extracted, filtered, and assayed as quickly as possible, essentially as described above.

Sensitivity of the Δ*phoU1* and Δ*phoU2* mutants to H~2~O~2~ and SDS. {#sec4-16}
---------------------------------------------------------------------

Overnight cultures of the S. epidermidis strains were diluted 1:200 in fresh TSB medium and incubated at 37°C for 3 h until an OD~600~ of 1 was reached. After 10-fold serial dilution, 5 μl of the aliquot was spotted onto a TSB agar plate containing 6 mM H~2~O~2~ or 0.006% SDS and incubated at 37°C overnight. The bacterial colonies on the plates were photographed and counted ([@B5], [@B31]).

MIC and MBC. {#sec4-17}
------------

The MICs of the antibiotics against the five S. epidermidis strains were determined using 2-fold serial dilutions of the antibiotics in Mueller-Hinton (MH) broth (Oxoid, Basingstoke, UK) according to CLSI guidelines ([@B67]). A log-phase culture (6 h) was adjusted to a turbidity equivalent to that of a 0.5 McFarland standard (10^8^ CFU/ml), inoculated into MH broth (1:200), and then incubated at 37°C for 16 to 20 h. The MIC endpoint was defined as the lowest concentration at which there was no visible growth in the tubes. The broth containing no drugs served as a control. The minimal bactericidal concentration (MBC) values were assessed by plating 100-μl samples from each negative culture tube (tubes with no visible bacterial growth) from the MIC assays onto blank MH broth agar plates. The MBC was the concentration at which a 99.9% reduction of the original inoculum was observed.

Determination of antibiotic-tolerant bacteria. {#sec4-18}
----------------------------------------------

Different antibiotics were added to the stationary-phase cultures (16 h) of the S. epidermidis strains (final concentrations, levofloxacin at 50 mg/liter, vancomycin at 75 mg/liter, and amikacin at 50 mg/liter), and then the cultures were incubated at 37°C for 120 h without shaking. One milliliter of the bacterial culture was then washed twice with ice-cold saline and pelleted by centrifugation for 3 min at 6,000 × *g*, and the pellet was resuspended in 1 ml cold saline, which was used to generate a series of 10-fold dilutions. Triplicate 5-μl aliquots from each dilution were spotted onto TSA plates for determination of the numbers of CFU ([@B5]). Three independent experiments were performed.

RNA isolation and RNA sequencing. {#sec4-19}
---------------------------------

Total RNA was isolated from strain SE1457 and the Δ*phoU1* and Δ*phoU2* mutants using an RNeasy minikit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions. Briefly, bacterial cultures were centrifuged at 5,000 × *g* for 5 min, and then the pellets were washed twice in 0.9% saline. The culture was homogenized 5 times using 0.1-mm zirconia-silica beads in a mini-BeadBeater (Biospec, Bartlesville, OK) at 4,800 rpm for 40 s at 1-min intervals on ice. The RNA extracted using the silica-based filter was purified with phenol-chloroform-isoamyl alcohol and precipitated with absolute ethanol.

RNA-Seq was performed according to the Illumina RNA sequencing sample preparation guide, using three biological replicates for each of the S. epidermidis strains. Samples of SE1457 and Δ*phoU1* and Δ*phoU2* mutant RNA were treated with RNase-free DNase I (TaKaRa) to prevent contamination with genomic DNA. The RNA quality was evaluated using a Bioanalyzer 2100 system (Agilent Technologies Deutschland GmbH). Prior to the sequencing analysis, rRNA was removed with a RiboZero rRNA removal kit for Gram-positive organisms. After depletion of the rRNA, fragmented RNA was used as a template for PCR with random primers. The cDNA libraries were prepared by using an mRNA-Seq sample preparation kit (Illumina). The concentration of cDNA was measured using a Qubit (version 2.0) fluorometer, the fragment size (200 to 300 bp) was verified on a Bioanalyzer 2100 system, amplification was performed using an Illumina cBot system, and sequencing was performed with an Illumina HiSeq 2500 sequencer for 51 cycles; all of these procedures were performed according to the manufacturers\' protocols. Raw sequencing data were processed using the data collection software provided by Illumina.

RNA-Seq data analysis and DEG validation by RT-qPCR. {#sec4-20}
----------------------------------------------------

Raw sequencing reads were preprocessed by filtering out rRNA reads, sequencing adapters, short fragment reads, and other low-quality reads. The remaining reads were mapped to the reference genome of S. epidermidis RP62A at the NCBI website with Bowtie2 software (version 2.0.5) on the basis of the local alignment algorithm. Reads that aligned to multiple locations were kept (to a maximum of 20 potential positions) to assist with the construction of gene models for genes with repetitive or low-complexity features. When the reads were aligned, 1 mismatch with the reference sequence was allowed. The alignments reported using Bowtie2 software were further processed with BEDTools software to determine the transcript expression levels and their differential expression between each two of the three samples. Expression values were presented as the number of reads per kilobase of genes per million mapped reads (RPKM). Data were visualized using the Integrated Genomics Viewer. Differential expression of all the transcripts was quantified using DEGseq software (version 2.16.1), and then the fold change values were presented. In general, we recorded no distinct difference between two transcripts when their fold change value fell between 0.666 and 1.5. Concomitantly, *P* values were determined, and significance was assessed by correcting for multiple testing using, for example, Fisher\'s exact test and the Wilcoxon test. Differentially expressed genes with corresponding expression values were uploaded into IPA software and analyzed using the canonical pathway. We used Fisher\'s exact test to select significant pathways, and the significance threshold was defined by a *P* value of 0.05. The significance of the pathway was indicated by the ratio of the number of genes from the data set that mapped to the pathway versus the total number of genes present in the canonical pathway.

For validation of DEGs identified by RNA-Seq, total RNA extracted from SE1457 and the Δ*phoU1* and Δ*phoU2* mutants was treated with the reagents from a PrimeScript RT reagent kit (TaKaRa Biotechnology, Dalian, China) for DNA digestion and reverse transcribed into cDNA. qPCRs were performed using a Mastercycler RealPlex system (Eppendorf AG, Hamburg, Germany) with SYBR green PCR reagents (SYBR Premix *Ex Taq*; TaKaRa Biotechnology, Dalian, China). The amplification conditions were 95°C for 30 s and 40 cycles of 95°C for 5 s and 60°C for 34 s, followed by a melting curve analysis. *gyrB* (DNA gyrase subunit B gene) was used as a housekeeping gene to normalize the transcript levels of the genes in the qPCR. All RT-qPCRs were performed in triplicate.

Construction of a protein-protein interaction network. {#sec4-21}
------------------------------------------------------

A protein-protein interaction network was constructed using Cytoscape software. A total of 174 DEGs encoding the candidate proteins involved in bacterial metabolism were extracted. The protein-protein interaction network was constructed according to the functional relationships annotated in the KEGG database (<http://www.genome.jp/kegg/pathway.html>). In the network, lines were used to represent protein-protein interactions, including binding/association, phosphorylation, activation, and inhibition. Proteins encoded by upregulated and downregulated DEGs are indicated in the figures in red and green, respectively.

Statistical analysis. {#sec4-22}
---------------------

Experimental data were analyzed with SPSS software and compared using the Student *t* test or one-way analysis of variance. Differences with a *P* value of \<0.05 were considered statistically significant.

Accession number(s). {#sec4-23}
--------------------

The complete RNA-Seq data set is posted in the Gene Expression Omnibus database (<http://www.ncbi.nlm.nih.gov/geo/>) under accession numbers [GSE97400](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97400) and [GSE97656](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97656) for the original data set.
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###### Supplemental material

Supplemental material for this article may be found at <https://doi.org/10.1128/JB.00219-17>.
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